Romiplostim
Orphan Drug Cold Chain RequiredFDA Approved
Contents
Description
Romiplostim is a thrombopoietin (TPO) receptor agonist. It is used to treat thrombocytopenia in adults with immune thrombocytopenic purpura (ITP).
Indications & Therapeutic Use
Autoimmune thrombocytopenia
Linked Diseases:
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Romiplostim — GNH India
16 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Augplat 250mcg
250mcginjection
Augplat 500mcg
500mcginjection
Nplate
EU
Romiset 250mcg
250 mcgvialsIndia
Romiset 500 mcg
250 mcgvialsIndia
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Romiplostim
| Generic Name | Romiplostim |
| Brands | 1 brand available |
| Active Ingredient | Romiplostim |
| Drug Class | Autoimmune thrombocytopenia |
| Manufacturer | Amgen |
| Dosage Forms | Subcutaneous injection, 250 mcg/vial, 500 mcg/vial |
| Medical Code | B02BX04 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00109453 |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes